newsfilter
← Latest News
GlobeNewswire·

Verve Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today